1
Return

Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomas

delete2026-06-08
delete0
PRE
AI
S
Sakibul Huq
T
Taylor A Gatesman
H
Hussam Abou-Al-Shaar
D
David R Raleigh
C
Constantinos G Hadjipanayis
J
James C Bayley
G
Georgios A Zenonos
T
Thomas M Pearce
D
Daniel F Marker
S
Sameer Agnihotri
P
Paul A Gardner *
DOI：10.1093/neuonc/noag136delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Population-based studies have linked progestin exposure to increased meningioma risk. However, the molecular basis of meningiomas associated with depot medroxyprogesterone acetate (DMPA) – a common injectable contraceptive—remains undefined.

Journal

N
Neuro-Oncology
IF:
13.4
Papers:
1.2W
Citations:
2.5W

Organization

N
new york university langone medical center
Scholars:
66
Papers: 31
Citations: 0
U
university of california san francisco
Scholars:
5.2W
Papers: 4.0W
Citations: 66
U
University of Pittsburgh Medical Center
Scholars:
784
Papers: 313
Citations: 9.4K
U
university of pittsburgh
Scholars:
5.1K
Papers: 2.3K
Citations: 1
Cited Papers

Cited Papers

Citing Papers

Citing Papers